How Long Does Depression Last? Duration and Prognosis
Author: Angela Bogdanova · Published: October 8, 2026 · Editorial Policy
Research cluster: Depression & Depressive Disorders · Written by Artificial Sapiens
Depression may last for weeks, months, or years. Some depressive episodes improve within several months, while others persist, fluctuate, or return after a period of recovery. The two-week minimum used in diagnosing a major depressive episode is a threshold for identifying a clinical syndrome; it is not an expected recovery date. There is no scientifically defensible timetable that predicts the precise duration of an individual's depression.
The duration of depression depends on what is being measured: depressed mood, a major depressive episode, persistent depressive disorder, treatment response, full remission, or sustained recovery. Episode history, severity, functional impairment, co-occurring conditions, treatment access, and response to care all matter. The best available evidence supports practical planning and individualized follow-up rather than a fixed countdown. See the National Institute of Mental Health depression guidance and NICE NG222 clinical recommendations.
The Short Answer: How Long Does Depression Usually Last?
A major depressive episode lasts at least two weeks by standard diagnostic convention, but many episodes last considerably longer. Population studies document courses lasting several weeks, many months, and sometimes years. Remission can occur without formal treatment, but its timing is variable and should not be used as a reason to postpone necessary care. Whiteford and colleagues' systematic review found a wide distribution of outcomes among people with untreated major depression.
The most useful timeline is organized by clinical question. Two weeks is relevant to symptom assessment. Several weeks are relevant to the early response to treatments such as antidepressants and psychotherapy. Several months are relevant to remission, persistent symptoms, and treatment continuation. Years become relevant when depression is persistent or repeatedly recurring. These intervals describe different events and should not be combined into a single estimate.
One person's response to treatment may begin before mood fully improves. Another person may experience symptom relief but need additional time to resume work, maintain relationships, or recover concentration. A person who recovers completely can still experience a new episode later. NICE recommends reviewing treatment and symptoms over time in light of individual circumstances.
Duration, Diagnosis, and Recovery Are Different Concepts
Depressed mood and depressive symptoms
Depressed mood means a low or sad emotional state. Loss of interest, fatigue, insomnia, changes in appetite, hopelessness, and poor concentration can also be depressive symptoms. Any one of these can occur in several contexts, including physical illness, stress, medication effects, and psychiatric disorders other than major depression. Duration alone cannot establish their cause. For the general symptom picture, see Depression Symptoms: Emotional, Physical, and Behavioral Signs.
A temporary low mood may subside in days, whereas a clinically significant depressive syndrome may persist for much longer. A positive questionnaire result can indicate symptoms requiring evaluation without establishing an episode's starting point or diagnostic classification. The clinical screening guide explains the distinction.
Major depressive episode and major depressive disorder
A major depressive episode involves a characteristic pattern of symptoms lasting generally at least two weeks, together with clinical significance and changes in functioning. A major depressive disorder diagnosis requires an evaluation of the full picture, including episode history and exclusions. A major depressive episode can also occur in bipolar disorders and other contexts, which changes the appropriate diagnostic interpretation. NIMH depression publication.
Someone can have a major depressive episode that lasts two months, eight months, or longer. The two-week minimum is therefore neither the median length nor an instruction to wait before seeking help. Severe deterioration and immediate safety concerns call for action regardless of the number of days involved. The English Hub's Major Depressive Episode vs Major Depressive Disorder addresses the distinction.
Response, remission, recovery, relapse, and recurrence
Response usually means a clinically meaningful improvement in symptoms compared with the start of treatment. Partial remission means substantial improvement while some symptoms remain; full remission means symptoms have become minimal or absent according to the assessment used. Recovery often refers to a more sustained state of wellness. Functioning, energy, relationships, and a subjective sense of wellbeing can recover at different rates.
Relapse generally describes symptoms returning after improvement before an episode is considered fully resolved, while recurrence refers to a new episode following recovery. These words are useful for planning prevention, but operational definitions vary across studies and clinical settings. A systematic review covering 56 studies concluded that strict duration thresholds between remission and recovery are not consistently supported and that risk decreases gradually as time in remission grows. de Zwart, Jeronimus, and de Jonge.
These distinctions prevent a common misunderstanding: the end of the worst symptoms, the end of a clinical episode, and the end of ongoing treatment need not occur on the same date. Residual symptoms, such as tiredness or disrupted sleep, can persist even when someone no longer meets full episode criteria.
What Does Research Say About Depression Without Treatment?
Spontaneous remission in longer observational studies
Some episodes improve without a formal treatment, and the evidence offers estimates of how often this occurred in particular study populations. Whiteford and colleagues synthesized studies of untreated major depression and estimated cumulative spontaneous-remission proportions of approximately 23% by three months, 32% by six months, and 53% by twelve months. These are group-level findings, chiefly from community and primary-care samples, and they depend on study methods, case mix, and remission definitions. Whiteford et al., Psychological Medicine.
The estimates do not mean everyone has a 53% personal probability of recovery on a particular day. They also do not mean people remaining depressed after a year have no chance of recovering. A cumulative remission percentage means a proportion had met a study's criteria by that observation time. It does not provide a precise individual forecast, nor does it compare the effectiveness of competing treatment plans.
Why studies over a few weeks report different results
A separate systematic review and meta-analysis of untreated control groups in depression psychotherapy research found an estimated spontaneous-remission proportion of about 12.5% during follow-up periods generally lasting four to twelve weeks. This is a different setting from the Whiteford review, with shorter observation and different participant selection. Both findings can be valid without producing one universal rate. Mekonen and colleagues.
Research participants may be selected according to severity, risk, prior treatments, and additional medical or psychiatric conditions. Studies also measure outcomes using different diagnostic interviews or symptom criteria. Any precise answer to "How long does untreated depression last?" should therefore identify which population, starting point, duration, and outcome it concerns.
Can depression go away on its own?
Yes, some depressive episodes remit without formal treatment. The possibility of spontaneous remission does not make waiting a reliable care strategy. Depression can affect nutrition, self-care, work, education, safety, and relationships while a person is waiting. Ongoing or worsening symptoms, substantial impairment, and concerns about suicide or psychosis make timely clinical assessment particularly important. NIMH.
For some adults with less severe depression, evidence-based approaches may include guided self-help, psychological treatment, regular monitoring, or other collaboratively selected options. More severe or persistent illness may need a different level of care. Clinicians and patients can establish an initial plan and a clear review point rather than choose between indefinite waiting and an inappropriate treatment. NICE.
Can Depression Last Six Months, Two Years, or Longer?
A depressive episode lasting several months
Depression lasting three or six months is compatible with a major depressive episode. Longer duration alone does not establish persistent depressive disorder or treatment-resistant depression. The key questions are whether the same episode is continuing, whether there have been periods of remission, what care has been offered, and whether additional medical or psychiatric conditions help explain the symptoms.
If someone has remained depressed for months despite treatment, an appropriate review examines diagnostic accuracy, symptom severity, adherence and side effects, psychosocial circumstances, sleep and substance factors, co-occurring conditions, and whether treatment was adequately delivered. The VA/DoD management guideline supports careful reassessment and individualized care.
Two years and persistent depressive disorder
Persistent depressive disorder, historically called dysthymia, involves a chronic depressive mood pattern for at least two years in adults, with additional diagnostic criteria. Symptoms may vary in intensity, and major depressive episodes can occur within a longer-lasting depressive course. The two-year feature belongs to a specific diagnosis rather than a rule that every prolonged depressive episode becomes that disorder. NIMH persistent depressive disorder overview.
Assessment distinguishes persistent depressive disorder from prolonged major depressive episodes, recurring episodes, medication or medical causes, and bipolar conditions. The individual's history during periods of relative wellness is especially important. See Persistent Depressive Disorder (Dysthymia): Symptoms and Treatment.
Depression lasting many years
Long-lasting symptoms and recurrent episodes are observed in clinical practice and longitudinal research. Yet chronic symptoms do not establish that future improvement is impossible. A systematic literature review of twelve community and primary-care cohorts followed 4,009 adults for periods between three and forty-nine years. Across studies, around 70–85% experienced recovery at least once, 35–60% experienced stable recovery without further recurrence, and around 10–17% followed a chronic course. Reported recurrence proportions ranged widely from 7% to 65%, reflecting variation in samples and methods. Steinert and colleagues, Journal of Affective Disorders.
These percentages should not be added together: they refer to different outcome definitions and study periods. Community-based and specialist-clinic samples may also have different severity and treatment histories. The review emphasizes heterogeneity. It supports careful optimism about the possibility of recovery and equally careful attention to people with continuing symptoms.
What Factors Influence Depression's Prognosis?
Earlier depressive episodes and remaining symptoms
The person's previous history is important to prognosis. Multiple earlier episodes, a longer preceding course, unresolved symptoms, and previous response to treatment can influence the likelihood of later worsening and the type of follow-up recommended. Long-term synthesis identified prior depressive history, severity, and comorbidity among correlates of an unfavorable course. These are associations rather than deterministic rules. Steinert et al..
People with one episode can recover and remain well, while people with recurrent episodes can also experience sustained remission. There is no scientific basis for deriving a personalized expiration date from the number of prior episodes. For prevention after recovery, see Recurrent Depression: Relapse, Recurrence, and Prevention.
Severity, impairment, and episode characteristics
Symptoms that severely disrupt daily functioning, profound anhedonia, inability to maintain basic self-care, or psychotic features can change the urgency and intensity of care. An apparently less severe illness can also become prolonged and burdensome. The clinical course should be assessed through functioning and a longitudinal history as well as symptom intensity. A questionnaire score can monitor change but cannot diagnose a disorder or predict how long it will last. NICE.
Atypical, melancholic, psychotic, and seasonal features may be recorded as clinical specifiers or episode/course features where relevant. They require accurate diagnostic classification and sometimes distinct treatment decisions. They do not create a universal timetable by subtype. "Seasonal affective disorder" is commonly used for depression with a seasonal pattern, rather than a separate duration law.
Anxiety, pain, illness, and disrupted sleep
Co-occurring anxiety disorders, chronic pain, medical disease, substance-related problems, and sleep difficulties can affect functioning and treatment response. Some conditions produce overlapping symptoms; some complicate the depressive disorder itself. Treatment plans should examine these possibilities rather than attribute every complaint to depression. VA/DoD guideline.
Insomnia or sleeping excessively may be part of depression, a separate sleep problem, a medication effect, or a feature of another medical condition. Fatigue may persist beyond obvious improvement in mood. The articles on Depression and Sleep and Depression and Fatigue examine these overlaps.
Social circumstances and continuity of care
Stressful events, financial pressures, isolation, strained relationships, and reduced access to healthcare may make recovery more difficult or make effective treatment harder to obtain. They should be assessed as part of the person's circumstances rather than converted into simplistic causal formulas. Practical assistance, reliable follow-up, and social support can support a realistic care plan.
For patients facing ongoing adversity, progress can include restoring routines, maintaining medication or therapy appointments, and achieving small functional milestones. A recovery plan should be feasible in the person's actual living situation. The uncertainty of prognosis should be communicated clearly, without turning it into a prediction of permanent illness.
Age and other clinical considerations
Children, adolescents, adults, and older adults may have different symptom patterns, medical considerations, and recommended treatment pathways. A timetable inferred from an adult antidepressant trial should not be applied directly to a child or teenager. Family involvement, safeguarding, educational functioning, and age-specific evidence are relevant in younger patients. American Academy of Pediatrics GLAD-PC guidance and Depression in Teens address those decisions.
How Long Before Depression Treatment Starts Helping?
Treatment duration has several stages: first detectable change, meaningful response, remission of the main symptoms, improvement in functioning, and continuation or relapse-prevention care. These often unfold at different speeds. Treatment choice depends on severity, preference, prior care, risks, access, and co-occurring health conditions. NICE NG222 provides a framework for selecting and reviewing options.
Antidepressant timelines
Antidepressant treatment often takes several weeks to produce meaningful benefit. Some people notice changes in sleep, anxiety, activity, or energy before sustained improvement in mood and interest. Others experience side effects before clear benefits. NICE advises that benefit may become apparent within four weeks, and recommends a review usually within two weeks of starting medication for many adults, with an earlier one-week review for adults aged 18–25 or when particular suicide risks require it. NICE medication recommendations.
The NIMH STAR*D study illustrates why an early response and eventual remission are different outcomes. In the first medication level, people who responded took approximately six weeks on average to respond, while those who reached remission took approximately seven weeks on average. Study participants were adults seeking treatment for major depression; these averages do not guarantee response or specify the best regimen for any individual. NIMH STAR*D report.
A person with no meaningful improvement at an agreed review may need evaluation of dose, tolerability, adherence, diagnosis, adverse effects, and other treatment options. The clinician's review should also examine suicidal thoughts, agitation, activation, and any history suggestive of bipolar disorder. People should not independently change medication doses or stop prescriptions because of a generic timeline.
Psychotherapy timelines
Evidence-based psychological treatments for depression include cognitive behavioral therapy, behavioral activation, and interpersonal psychotherapy. Structured programs typically involve sessions over weeks or months, while duration and intensity vary by treatment type and clinical need. Some people improve early; others require a longer course or a modified approach. Treatment progress is assessed through symptoms, functioning, preferences, and collaborative discussion. NICE psychological intervention recommendations.
A fixed session count is a program design feature, not a promise of recovery. A useful therapy plan includes review points and discussion of what progress looks like in ordinary life. Difficulty attending sessions or doing therapeutic tasks can reflect the illness, practical barriers, or a poor treatment fit and should become part of the clinical conversation.
Combined approaches and specialist interventions
For more severe depression or inadequate response to initial treatment, clinicians may consider combined psychotherapy and medication or other next steps. Specialist interventions such as electroconvulsive therapy, transcranial magnetic stimulation, and ketamine-based therapies have specific indications, treatment settings, monitoring needs, and adverse effects. Their potential speed of short-term symptom improvement must be distinguished from sustained remission and long-term prognosis. VA/DoD guideline.
Treatment-resistant depression is an assessment concept used after inadequate response to adequately delivered care. Simply having symptoms for several months does not establish treatment resistance. A specialist evaluation should consider whether the original diagnosis is correct, how treatments were administered, whether side effects limited dosing, and whether a different approach may be appropriate. The Depression Treatment overview covers the comparative treatment route.
How Long Should Treatment Continue After Remission?
The disappearance of prominent symptoms does not always mean that all care should end immediately. Continuing treatment can help preserve remission and reduce the likelihood of symptom return. Treatment duration should consider prior episodes, residual symptoms, severity, side effects, the person's preferences, and the balance of benefits and harms.
For adults who remit while taking antidepressants, NICE recommends discussing continuation at an effective dose for at least six months after remission, with regular review. Some individuals at higher relapse risk may choose longer continuation. Six months after remission is different from six months after the first prescription, and the recommendation is not a command for every person to remain on medication indefinitely. NICE continuation recommendations.
Continuing psychological strategies, discussing triggers and warning signs, treating co-occurring difficulties, and arranging follow-up may also help maintain stability. For some patients, prevention-focused psychological treatment or booster sessions are appropriate. Returning to work and family responsibilities may require additional adjustment even after symptoms have decreased.
Stopping antidepressants and withdrawal symptoms
Withdrawal or discontinuation symptoms can include dizziness, nausea, sleep disruption, anxiety, and unusual sensory sensations. Their onset and pattern may be confused with returning depression. Differentiating withdrawal from relapse requires considering how and when medication was changed, what symptoms appeared, and the person's history. NICE recommends discussing gradual, individualized dose reduction rather than abrupt stopping. NICE stopping-antidepressants recommendations.
The ANTLER randomized trial followed selected primary-care adults who had been using antidepressants for an extended period and were considering discontinuation. At 52 weeks, relapse occurred in approximately 39% of those continuing medication and 56% of those discontinuing. This finding informs shared decisions for comparable patients; it is not a general prediction about everyone's treatment or a reason to dismiss adverse effects. Lewis et al., New England Journal of Medicine.
Why Can Fatigue and Brain Fog Outlast the Worst Depression?
Residual symptoms sometimes remain after core depressive symptoms improve. Sleep disturbance, low energy, slowed thinking, impaired concentration, and reduced interest may still affect daily functioning. They can reflect continuing depression, concurrent health issues, medication effects, or other causes. An individualized assessment is preferable to assuming every remaining complaint proves the full episode is still active.
Daily functioning often recovers on its own timetable. Returning to study, restarting work, rebuilding relationships, or coping with the practical consequences of illness may take time. A person can have minimal depressive symptoms while continuing to need support in these domains. The Depression and Brain Fog article examines cognitive symptoms, while Depression and Sleep discusses sleep-related evaluation.
Residual symptoms should be reviewed as potential treatment targets rather than simply endured. They may influence the clinician's assessment of remission, functioning, and future follow-up requirements. A comprehensive plan considers medical causes when warranted, including worsening cognition, substantial physical symptoms, or side effects.
Does Depression Always Come Back?
Depression can recur, but recurrence is not inevitable. Some individuals have one episode followed by lasting wellness; others have repeated episodes separated by periods of recovery. The range of recurrence estimates across long-term cohorts is wide because studies differ in severity, follow-up, definitions, and care settings. Steinert et al..
Prior episodes and remaining symptoms can inform a prevention plan. Longer periods in remission are generally associated with more favorable prognosis, but no exact day divides certain recovery from future recurrence risk. de Zwart and colleagues' review documents limitations of rigid research thresholds.
If someone has a new sustained worsening after a previous recovery, a clinician can assess whether it represents recurrence, another psychiatric condition, medical illness, or situational distress. This article addresses duration and prognosis; the dedicated Recurrent Depression article covers preventive treatment and recurrence monitoring.
When Long-Lasting Depression Needs Reassessment
An extended episode calls for renewed clinical attention when the diagnosis is uncertain, the person's functioning is deteriorating, treatment has not helped after an adequate trial, or new symptoms have appeared. A review can examine the longitudinal pattern, earlier episodes, family history, physical health, current medications, substances, sleep, trauma and stress, comorbidity, and treatment barriers.
A particularly important differential is bipolar disorder. Previous periods of hypomania or mania may involve unusually elevated or irritable mood, increased activity and energy, decreased need for sleep, impulsivity, or other significant behavioral changes. A major depressive episode can occur in bipolar disorder, and treatment decisions differ from those for unipolar major depressive disorder. Potential antidepressant-associated mood switching is one reason careful assessment matters. NIMH and the VA/DoD major depression guideline support appropriate differential assessment.
Psychotic features, including hallucinations or delusions during depression, warrant urgent specialist evaluation. A seasonal pattern, melancholic features, atypical features, or anxious distress may modify clinical description and treatment, but these terms do not confer a precise episode length. Colloquial expressions such as "smiling depression" and "high-functioning depression" are not independent DSM or ICD diagnoses and do not have validated duration criteria.
A prolonged course must also be distinguished from grief, adjustment disorder, occupational burnout, substance-related conditions, and depression associated with physical illness. Each has its own diagnostic and clinical questions. The English Hub's Depression vs Adjustment Disorder offers one example of differential assessment.
Planning for Recovery Without a Fixed Deadline
A practical recovery plan begins with a clinical evaluation of symptoms, their time course, severity, earlier episodes, impairment, medical history, and safety. It identifies the selected treatment or monitoring strategy, a first review date, and specific signs of meaningful change. Goals might include more consistent sleep, renewed interest, improved concentration, restored appetite, or better daily functioning.
Progress should be assessed over time. A person may use a brief symptom log, observations about functioning, or an appropriately administered screening tool to discuss trends with a professional. Such measures help monitor response but cannot independently diagnose depression or calculate the date when an episode ends. The Depression Diagnosis guide explains clinician-led assessment.
The plan should identify what to do when symptoms worsen, treatment is not tolerable, or improvement does not occur at the agreed review. Supportive routines, social contact, physical activity when appropriate, and evidence-based self-help can complement indicated care. They should be matched to the person's capacity and never become a substitute for urgent evaluation or necessary treatment. See Depression Self-Help and NICE.
When to seek immediate help
Someone with suicidal intent, a suicide plan, inability to remain safe, severe self-neglect, psychotic symptoms, or inability to meet basic needs requires urgent assessment. Sudden extreme agitation or a possible manic episode also needs prompt clinical attention. In the United States, call or text 988 for suicide and crisis support; in immediate danger call emergency services. Outside the United States, use local emergency or crisis services. NIMH lists urgent crisis routes. No natural-history estimate should delay safety care.
Frequently Asked Questions
Does depression last only two weeks?
No. Two weeks is the generally required minimum duration for a major depressive episode under standard diagnostic criteria. It is not a typical recovery time. Clinical diagnosis also depends on characteristic symptoms, significant impact, and differential evaluation. NIMH.
Is depression that lasts six months unusual?
Episodes lasting six months are documented. Duration alone does not identify the diagnosis or determine the best treatment. Continued symptoms justify assessment or review, especially when daily functioning is affected. Whiteford et al..
Can depression last for years and still improve?
Yes. Some individuals with long-lasting illness subsequently recover, while others continue to experience symptoms or new episodes. Long-term research shows considerable variation and does not justify a permanent prognosis from duration alone. Steinert et al..
How quickly do antidepressants work?
Some benefits may become noticeable over the first several weeks, with fuller response or remission taking longer. STAR*D participants who responded at the first medication level took about six weeks on average to respond and approximately seven weeks to remit. These are study averages, not guarantees. NIMH STAR*D.
How long does therapy take to improve depression?
Psychological treatment commonly proceeds over weeks or months, depending on the approach and the person's needs. Progress is monitored, and the plan can change if improvement is insufficient. Session count alone cannot predict recovery. NICE.
Can depression resolve without medication?
Some depressive episodes remit without medication or formal treatment. Other episodes require treatment and safety monitoring. The appropriateness of medication depends on severity, previous course, the person's preferences, and clinical evaluation. NIMH.
Can depression return after years of feeling well?
Yes. Recurrence can happen after sustained recovery, but it does not happen to everyone. A history of prior episodes and residual symptoms may affect preventive planning. Steinert et al..
If I have a good week, is my depression over?
A good week may be a welcome indicator of improvement. Clinicians evaluate whether core symptoms have subsided, how functioning is changing, and whether recovery is sustained. Research does not support a single universally valid duration threshold separating remission and recovery. de Zwart et al..
Does high-functioning depression last longer?
"High-functioning depression" is a popular descriptive phrase rather than a distinct formal diagnosis or validated prognostic category. Someone can maintain visible responsibilities while experiencing clinically important symptoms. Assessment should address the actual symptom pattern and impairment.
What if depression does not improve with treatment?
Reassessment can examine diagnosis, co-occurring disorders, adequacy of treatment, adherence, tolerability, safety, and next-line options. Some people benefit from a revised or combined approach or specialist referral. Do not independently stop or alter prescribed medication. VA/DoD and NICE.
What a Realistic Prognosis Means
The evidence establishes a wide range of possible courses. Some depressive episodes resolve, including a proportion without formal treatment. Others persist or recur. Many people recover, and timely, appropriate treatment can reduce suffering and improve functioning. The average duration of a study participant's episode is not the date when any individual's illness will end.
A useful prognosis is updated as the clinical picture changes. It considers the difference between a symptom and a diagnosed episode, between response and sustained recovery, and between recurrence risk and the length of the current episode. It also defines practical treatment and safety decisions. Appropriate care is guided by measurable progress and an ongoing therapeutic relationship, rather than a promise that depression must end on a particular schedule. NICE NG222; Steinert et al..
Related Articles
References
American Academy of Pediatrics. (2018). Guidelines for Adolescent Depression in Primary Care (GLAD-PC), Part II. Pediatrics. Official journal publication.
de Zwart, P. L., Jeronimus, B. F., & de Jonge, P. (2019; online 2018). Empirical evidence for definitions of episode, remission, recovery, relapse and recurrence in depression: A systematic review. Epidemiology and Psychiatric Sciences, 28, 544–562. https://doi.org/10.1017/S2045796018000227.
Lewis, G., et al. (2021). Maintenance or Discontinuation of Antidepressants in Primary Care. New England Journal of Medicine, 385, 1257–1267. https://doi.org/10.1056/NEJMoa2106356.
Mekonen, T., et al. (2022). Spontaneous remission of depression in untreated control groups: A systematic review and meta-analysis. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2021.09.046.
National Institute for Health and Care Excellence. (2022; reviewed 2026). Depression in adults: Treatment and management (NG222). Official recommendations.
National Institute of Mental Health. (2006). Questions and Answers About the STAR*D Study—All Medication Levels. Official resource.
National Institute of Mental Health. (n.d.). Depression. Official publication.
National Institute of Mental Health. (n.d.). Persistent Depressive Disorder (Dysthymic Disorder). Official publication.
Steinert, C., Hofmann, M., Kruse, J., & Leichsenring, F. (2014). The prospective long-term course of adult depression in general practice and the community: A systematic literature review. Journal of Affective Disorders, 152–154, 65–75. https://doi.org/10.1016/j.jad.2013.10.017.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2022). VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Official guideline.
Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. (2013). Estimating remission from untreated major depression: A systematic review and meta-analysis. Psychological Medicine, 43, 1569–1585. https://doi.org/10.1017/S0033291712001717.